NORGES BANK - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORGES BANK ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$270,000
-84.6%
11,600
-87.4%
0.00%
Q3 2021$1,753,000
+34.8%
92,200
+42.9%
0.00%
Q2 2021$1,300,000
+162.1%
64,500
+158.0%
0.00%
Q3 2019$496,000
+137.3%
25,000
+39.1%
0.00%
Q4 2014$209,000
-84.1%
17,968
-84.1%
0.00%
-100.0%
Q3 2014$1,316,000112,9680.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders